Melanocytic nevus
MONDO:0005073A neoplasm composed of melanocytes that usually appears as a dark spot on the skin.
Also known as: melanocytic Nevus, melanotic Nevus, mole, mole of skin, nevus
1516 clinical trials for this condition and its sub-types, 17 tagged with Melanocytic nevus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Melanocytic nevus
-
CHILD syndrome 37 trials
-
Large congenital melanocytic nevus 7 trials
-
Neutrophil actin dysfunction 6 trials
-
CLOVES syndrome 5 trials
-
Hereditary mucosal leukokeratosis 3 trials
2 sub-types
- White sponge nevus 1 0 trials
- White sponge nevus 2 0 trials
-
Benign melanocytic skin nevus 0 trials · 2 incl. sub-types
2 sub-types
- Spitz nevus 2 trials Sub-types →
- Desmoplastic nevus 0 trials Sub-types →
-
Blue nevus 1 trial
-
Halo nevus 1 trial
-
Neurocutaneous melanocytosis 1 trial
-
Nevus, epidermal 1 trial
1 sub-type
- Wooly hair nevus 0 trials
-
Palpebral nevus 0 trials · 1 incl. sub-types
1 sub-type
- Linear nevus sebaceous syndrome 1 trial
-
Angora hair nevus 0 trials
-
Becker nevus syndrome 0 trials
1 sub-type
-
Nevada syndrome 0 trials
-
PENS syndrome 0 trials
-
Congenital panfollicular nevus 0 trials
-
Conjunctival nevus 0 trials
-
Didymosis aplasticosebacea 0 trials
-
Intradermal nevus 0 trials
-
Linear verrucous nevus syndrome 0 trials
3 sub-types
- Acanthokeratolytic verrucous nevus 0 trials
- Inflammatory linear verrucous epidermal nevus 0 trials
- Verrucous nevus 0 trials
-
Nevus comedonicus syndrome 0 trials
-
Nevus of Ito 0 trials
-
Nevus of Ota 0 trials
-
Phakomatosis pigmentokeratotica 0 trials
-
Pigmented spindle cell nevus 0 trials
-
Scalp syndrome 0 trials
Most studied deeper sub-types
-
New hope for rare blood vessel disorders: everolimus trial launches
Disease control Not yet recruitingThis phase 2 trial tests the drug everolimus in 67 people with vascular anomalies (abnormal blood vessels) that haven't responded to standard treatments. The goal is to shrink the lesions and improve symptoms. Participants take everolimus daily for 6 months, with doses adjusted b…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
AI-Powered 3D scanner could spot skin cancer before it spreads
Diagnosis Not yet recruitingThis study aims to develop an artificial intelligence system that can automatically detect potential melanomas using 3D whole-body skin images. Researchers will collect scans from 1,000 adults with many moles and compare the AI's findings to those of three skin specialists. The g…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC